Home › Membranous Glomerulonephritis › Florida
Membranous Glomerulonephritis clinical trials in Florida
3 studies for Membranous Glomerulonephritis are looking for participants at sites in Florida.
Cities in Florida
A Phase 3 Study of Inebilizumab in Participants With Primary Membranous Nephropathy
- Bioresearch Partner-Jackson West, Doral
- Bioresearch Partner- Martin Luther King Jr., Miami
- Bioresearch Partner- Pembroke Pines, Pembroke Pines
RecruitingPhase 3
Ages 18 to 79 · All sexes · Updated Oct 1, 2026 · NCT07851220Belimumab With Rituximab for Primary Membranous Nephropathy
- Mayo Clinic Jacksonville: Department of Nephrology and Hypertension, Jacksonville
- University of Miami Miller School of Medicine, Div of Nephrology, Miami
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Sep 18, 2026 · NCT03949855Nephrotic Syndrome Study Network
- University of Miami Miller School of Medicine, Miami
RecruitingObservational study
Up to age 80 · All sexes · Updated Jun 10, 2026 · NCT01209000From ClinicalTrials.gov, data retrieved Oct 2, 2026. Each study sets its own eligibility; the study team decides who can join.